• Facebook
  • Twitter
  • LinkedIn
PHYSIDIA
  • PATIENTS
    • Renal insufficiency
    • Home hemodialysis
    • Physidia services
    • Testimonial
    • FAQ
  • PROFESSIONALS
    • Benefits of daily hemodialysis
    • SeCoHD therapy
    • Our products
    • Testimonials
    • FAQ
  • ABOUT US
    • Our team
    • Our commitments and mission
    • Physidia network
    • Video presentation
  • NEWS
  • CONTACT
Select Page
β2M removal – a study on middle molecules elimination with home hemodialysis

β2M removal – a study on middle molecules elimination with home hemodialysis

by Jean-Paul Haber | Mar 12, 2021 | News

SINGLE SESSION and WEEKLY BETA 2 MICROGLOBULIN REMOVAL DURING SHORT FREQUENT HEMODIALYSIS USING PHYSIDIA TECHNOLOGY Physidia publication at the 2021 ADC conference β2M removal – a study on efficiency of middle molecules elimination with short frequent hemodialysis The...

Recent Posts

  • ERA Congress, 60th Anniversary
  • Physidia announces growth investment from Columna Capital to accelerate international expansion
  • Les Maux à Vélo, a cycle trip
  • Our exclusive partner in the UAE organized their official launch symposium
  • Europe’s fastest-growing companies, Physidia rewarded

Recent Comments

    Archives

    • June 2023
    • May 2023
    • March 2023
    • September 2022
    • July 2022
    • October 2021
    • September 2021
    • August 2021
    • June 2021
    • May 2021
    • March 2021
    • July 2019
    • June 2019
    • May 2019
    • September 2018

    Categories

    • Events
    • La dialyse à domicile-en
    • News
    • Non classé
    • Produits-en

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Homepage
    • Patients
    • Professionals
    • About us
    • News
    • Contact
    • Legals
    • Facebook
    • Twitter
    • LinkedIn